Yes, bone marrow can be frozen, and it is done thousands of times a year for stem cell transplants. The catch is that the marrow must be processed and treated with a cryoprotectant before it ever reaches a freezer, then cooled at a controlled rate to around minus 80°C or colder. Left in a home freezer without that treatment, marrow cells rupture and die. So can you freeze bone marrow? Yes, but only under laboratory conditions, not in a kitchen. What follows explains the biology, the cryoprotectant chemistry, and the storage limits.
What Makes Marrow Hard to Freeze
Bone marrow is a suspension of hematopoietic stem cells, fat, red cells, and plasma proteins. Water makes up roughly 80% of its cellular content, so the real problem is ice. As temperatures drop below the freezing point, water leaves the cells and forms extracellular ice crystals. Freezing is a race between ice crystal nucleation and water removal from cells, which is why cooling rate matters enormously.
Cool too slowly, and the cells shrink below a lethal volume as solute concentration outside them spikes. Too fast, and intracellular ice forms, shredding membranes.
Cryoprotectants like dimethyl sulfoxide (DMSO) change the rules. DMSO penetrates cell membranes, forms hydrogen bonds with water, and lowers the freezing point. It lets water remain unfrozen at temperatures where pure water would crystallize. Marrow is typically equilibrated in a final DMSO concentration of about 5% to 10% before cooling.
The Physics of Cryoprotection
Successful marrow freezing rests on two mechanisms acting together. The first is solute-mediated water withdrawal: as extracellular ice forms, the remaining liquid gets more concentrated, and cells lose water by osmosis until intracellular ice is impossible. The second is vitrification: at a high enough cryoprotectant concentration and a fast enough cooling rate, the remaining liquid becomes a glass rather than ice.
Human marrow sits between those strategies because high DMSO concentrations are toxic to stem cells at warm temperatures. This is why protocols use a controlled-rate freezer that drops temperature about 1°C per minute between nucleation and roughly minus 40°C. In plain terms, the machine lets cells dehydrate gently before deep cold sets in.
Timing and Temperature at Every Stage
The table below lays out the typical steps for a marrow or stem cell product headed for cryopreservation. The exact numbers vary by lab and accreditation standard, not by marketing.
| Stage | Typical range | What happens |
|---|---|---|
| Collection to processing | 4–24 hours at 20–24°C | Cell viability declines with delay |
| Cryoprotectant addition | 5–10% final DMSO | Water bound, ice formation delayed |
| Controlled cooling | 1°C per minute to −40°C or lower | Extracellular ice forms; cells dehydrate |
| Transfer to storage | −80°C mechanical or −196°C liquid nitrogen | Vitrification at ultra-low temperatures |
| Viability after thaw | Varies by method and hold time | DMSO must be removed for infusion |
| Long-term storage window | Many years at −196°C | Colder is more stable |
The variance across stages is real. Processing delays beyond about 24 hours measurably reduce cell recovery, and DMSO concentration above roughly 10% is generally avoided because toxicity outweighs added protection.
How Long Can Frozen Marrow Last
Storage temperature determines shelf life far more than any single protocol detail. At minus 196°C in liquid nitrogen vapor, metabolic and chemical reactions are effectively arrested, and accredited centers routinely maintain stem cell products for years. A transplant can only proceed after thawing at 37°C and washing out DMSO within minutes, because the cryoprotectant becomes toxic quickly once warm.
Here the quantitative context matters. A clinical unit of marrow is typically 200–1,000 mL and is often processed down to a buffy coat or mononuclear cell concentrate. Cell doses for transplant are conventionally reported in the range of 2–5 × 10^8 mononuclear cells per kilogram of recipient body weight. Those figures drive how much product a single collection can supply.
What Freezing Cannot Do
Freezing does not sterilize. Pathogens present before collection survive cryopreservation, and a freezer cannot rescue cells from collection injury. Whole marrow, given as a product, is bulky and rich in red cells that must be reduced before freezing in many settings. Viability after thaw is often quoted as a percentage, but the metric itself is fuzzy: which cells count, and how they are measured, changes the number.
One professional caveat deserves emphasis: intact, thawed stem cell viability is not the same as engraftment potential. A product can look well preserved under a microscope and still fail to reconstitute marrow. Cell dosing and recipient conditioning influence outcomes more than the cryopreservation step alone.
A counterintuitive detail closes this section. Slow cooling is the gold standard precisely because it is gentler, but a little extracellular ice actually protects the cells by pulling water from them. Perfect avoidance of ice formation is not the goal; controlled ice formation is.
Common Myths About Frozen Marrow
Several misconceptions surround frozen marrow, and clearing them prevents expensive mistakes. The biggest is that a home freezer can do the job. The second is the idea that freezer temperature alone guarantees survival.
To keep this practical, here is what still goes wrong:
Using a standard freezer at −18°C without a cryoprotectant destroys the cells. Believing no ice at all is better; controlled extracellular ice protects cells. Treating DMSO as harmless; it is toxic to stem cells once warmed. Assuming microscopic viability predicts transplant success. Leaving marrow at room temperature beyond the acceptable processing window.
The home-freezer myth needs a direct answer. Supermarket freezers hold foods near minus 18°C, but human cellular products for transplant demand far colder storage and exact protocols. Frozen marrow meant for transplant is a regulated tissue product, not a freezer bag.
Comparing Storage Options
Different storage temperatures serve different purposes, and the differences in cell survival are large. The table below compares common options.
| Storage method | Temperature | Best use | Effect on stem cells |
|---|---|---|---|
| Home freezer | About −18°C | None for cells | Intracellular ice, cell death |
| Mechanical freezer | −80°C | Intermediate shipping or storage | Practical but finite stability |
| Liquid nitrogen vapor | Around −190°C | Long-term stem cell banking | Metabolic arrest, high survival |
| Liquid nitrogen immersion | −196°C | Archive storage | Similar, with handling risks |
| Controlled-rate freezer run | To −40°C or lower | Pre-storage step | Set cooling rate precisely |
| Refrigerated shipping | 2–8°C | Short transport only | Best for cells if very fresh |
The key comparison is −80°C versus −196°C. A mechanical freezer is common for short-term holds but is generally less stable for years of storage. Liquid nitrogen vapor is the usual standard for long-term banking.
Different standards use different drying and freezing metrics, and they do not fully align. Cryobiologists often talk about cooling rates near 1°C per minute, while storage guidelines emphasize that colder is more stable. Reconcile them this way: the rate protects during freezing; the final temperature protects during storage. Both matter.
Practical Steps for Handling Frozen Marrow
Whether you are in a clinical lab or responding to an information request, concrete steps matter more than theory. These are the actions that preserve viability from collection to thaw.
Confirm the collection-to-processing window and keep the product at 20–24°C until processing begins. Add cryoprotectant to a final DMSO concentration around 5–10% under validated lab procedure. Use a controlled-rate freezer to cool at roughly 1°C per minute to −40°C or lower. Transfer to −80°C only for short intervals, or to liquid nitrogen vapor for long-term storage. Thaw rapidly at about 37°C and wash out DMSO soon afterward under clinical protocol. Record every temperature and time stamp; storage failures are traceability failures.
These steps are procedural, not a treatment plan. Anyone preparing human cells for clinical use must follow accredited tissue-banking rules and institutional protocols, not a general explainer.
Limits of the Science and the Guidelines
The biggest limitation is that there is no single universal protocol. Centers differ in DMSO concentration, freezing rate, storage container, and thaw washing. Published thresholds are conventions, not hard physics. Guidelines from major organizations recommend ranges but leave room for validation studies, and the differences matter more for borderline products than for robust ones.
A second limit is that long-term storage data are collected from real inventories, not controlled experiments. Records therefore describe what happened at each center rather than proving an absolute maximum storage duration. Freezing defends the potential of marrow; clinical outcome depends on collection quality, cell dose, and the recipient's condition.
A final reason for careful language: this is cellular preservation science, not a route to diagnosing or treating any specific disease. The mechanism is stable. The clinical decisions belong to qualified specialists.
Takeaway
Bone marrow freezes well only after cryoprotection and controlled cooling. DMSO prevents lethal ice, controlled-rate cooling allows gentle dehydration, and temperatures near minus 80°C or colder hold the product in storage. The hard limits are biological, the protocols are procedural, and the success of the freeze is measured by what happens after thaw.
Citations
U.S. Food and Drug Administration. Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps): current good tissue practice regulations. 21 CFR Part 1271. Centers for Disease Control and Prevention. Guidance on collection, processing, and storage of hematopoietic stem cells. American Society for Transplantation and Cellular Therapy. Cryopreservation and processing recommendations for hematopoietic stem cell products. World Health Organization. Guidance on tissue banking and cellular therapy product handling.
One plain-language recap: frozen marrow works because the cells are chemically primed and cooled slowly, not because the freezer is cold.